ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower‐risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo‐controlled trial

Study limitation reported by the research below: “Clonal growth rate over 12 months showed minimal change in both arms (~3–5% VAF increase per year), raising questions about its suitability as a surrogate endpoint for treatment efficacy in this population.”

Papers